Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil with esketamine versus sufentanil with ketorolac versus sufentanil alone for postoperative analgesia after rhinologic surgery
ChiCTR2100041810Phase 4Recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sufentanil, esketamine and ketorolac in acute postoperative pain (3 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: Pain score at PACU discharge and postoperative time points and Adverse effects and patient satisfaction. Started Jan 2021; status: recruiting.
02
Drugs
sufentanilesketamineketorolac
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2100041810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041810.